<DOC>
	<DOCNO>NCT01335061</DOCNO>
	<brief_summary>The purpose study determine once-weekly prophylaxis regimen BeneFIX subject moderately severe severe Hemophilia B safe effective .</brief_summary>
	<brief_title>Study To Compare On-Demand Treatment To A Prophylaxis Regimen Of BeneFIX In Subjects With Moderately Severe Severe Hemophilia B</brief_title>
	<detailed_description />
	<mesh_term>Hemophilia A</mesh_term>
	<mesh_term>Hemophilia B</mesh_term>
	<criteria>Documented history moderatelysevere severe hemophilia B ( FIX activity &lt; /=2 % ) . Male subject , age 12 year 65 year . Subjects least 100 exposure day ( EDs ) factor IX product . Subjects minimum 12 bleed episode , 6 must joint bleeds , 12month period Screening visit . Subjects received FIX primary secondary prophylaxis regimen within last 12 month prior Screening visit . Subjects major surgery orthopedic surgical procedure within past 3 month prior Screening visit . Subjects major surgery orthopedic surgery plan within duration study participation . Subjects past history , current FIX inhibitor , define &gt; ULN ( upper limit normal ) report laboratory . Subjects know hypersensitivity FIX product hamster protein .</criteria>
	<gender>Male</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Hemophilia B</keyword>
	<keyword>on-demand</keyword>
	<keyword>prophylaxis</keyword>
	<keyword>nonacog alfa</keyword>
	<keyword>BeneFIX</keyword>
	<keyword>FIX</keyword>
</DOC>